Saturday 11 November 2023

GALVANIZE: Fw: NOW CASTING Real Paxlovid Users - Nationwide Casting!




----- Forwarded Message -----
From: "Spark Casting" <apply@sparkcasting.com>
To: "aakhu2@aol.com" <aakhu2@aol.com>
Cc:
Sent: Sat, Nov 11, 2023 at 5:43 PM
Subject: NOW CASTING Real Paxlovid Users - Nationwide Casting!
Hi Aakhu -
 
We are casting a new project! Have you or someone you know taken the medication PAXLOVID?
 
We're seeking REAL Paxlovid users (AGES 30-60) who have a high-risk factor that could lead to severe illness from COVID-19. Looking for real stories that will help others understand the positive effects of Paxlovid as a treatment for COVID-19. Pay is $1500!
 
Applicants would need to be available in early JANUARY 2024. NATIONWIDE CASTING - the client will travel to YOU! 
 
This is a time-sensitive project. If you're interested in the next steps, more details and the application can be found at the link below.
 
 
If you have any issues with the link, please copy and paste in your browser. 
 
 
This is a TIME-SENSITIVE project. If you're interested in the next steps, more details and the application can be found at the link below.
Looking forward to getting you in the mix on this project!
 
 
Spark Casting Team
Follow us on Instagram, TikTok, and Twitter!
 

--
--
gal`va`nize: to stimulate people into sudden activity; to provide a network for DC metropolitan theatre artists, specifically those of the African diaspora, in order to connect, support and encourage each other because "we are all far too beautiful to be so seen so little".
 
INVITE A FRIEND TO JOIN GALVANIZE/CHANGE YOUR CURRENT SUBSCRIPTION:
http://groups.google.com/group/galvanize

---
You received this message because you are subscribed to the Google Groups "Galvanize" group.
To unsubscribe from this group and stop receiving emails from it, send an email to galvanize+unsubscribe@googlegroups.com.
To view this discussion on the web visit https://groups.google.com/d/msgid/galvanize/1027245937.1970883.1699743354567%40mail.yahoo.com.

0 comments:

Post a Comment